Clinical Trial Update: Thalidomide in Treating Anemia in Patients With Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating thalidomide for anemia in patients with myelodysplastic syndromes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Myeloproliferative Neoplasms
• Myelodysplastic Syndromes

Drugs mentioned

• Thalomid (thalidomide)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED